Oxford vaccine trial pause won't have impact on Indian trials: Serum Institute CEO

After clinical trials of the Covid-19 vaccine developed by the Oxford University and AstraZeneca have been halted after a participant had an adverse reaction in the UK-- Serum Institute of India has issued a statement to clear the air on the impending trials of the vaccine in India.

"Nothing untoward has been reported during the vaccine trials in India," Serum Institute CEO Adar Poonawalla told India Today on Wednesday.